DE3751218D1 - Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen. - Google Patents

Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.

Info

Publication number
DE3751218D1
DE3751218D1 DE3751218T DE3751218T DE3751218D1 DE 3751218 D1 DE3751218 D1 DE 3751218D1 DE 3751218 T DE3751218 T DE 3751218T DE 3751218 T DE3751218 T DE 3751218T DE 3751218 D1 DE3751218 D1 DE 3751218D1
Authority
DE
Germany
Prior art keywords
treatment
methods
coagulation disorders
therapeutic preparations
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751218T
Other languages
English (en)
Other versions
DE3751218T2 (de
Inventor
Donogh Paul O'brien
Gordon Allen Vehar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25453974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3751218(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE3751218D1 publication Critical patent/DE3751218D1/de
Application granted granted Critical
Publication of DE3751218T2 publication Critical patent/DE3751218T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE3751218T 1986-11-04 1987-11-02 Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen. Expired - Lifetime DE3751218T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92697786A 1986-11-04 1986-11-04

Publications (2)

Publication Number Publication Date
DE3751218D1 true DE3751218D1 (de) 1995-05-11
DE3751218T2 DE3751218T2 (de) 1995-11-09

Family

ID=25453974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751218T Expired - Lifetime DE3751218T2 (de) 1986-11-04 1987-11-02 Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.

Country Status (8)

Country Link
EP (1) EP0266993B1 (de)
JP (1) JP2758162B2 (de)
AT (1) ATE120645T1 (de)
CA (1) CA1317878C (de)
DE (1) DE3751218T2 (de)
ES (1) ES2073391T3 (de)
NZ (1) NZ222434A (de)
ZA (1) ZA878249B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) * 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
EP0417298A4 (en) * 1989-02-02 1993-03-10 Teijin Limited Detection of human tissue factor activator
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
BR9806793A (pt) 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
JP2002520297A (ja) 1998-07-13 2002-07-09 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム アミノリン脂質に結合する治療結合体を用いる癌処置方法
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
WO2000004148A1 (en) 1998-07-15 2000-01-27 Genentech, Inc. Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
US6703494B2 (en) 2000-03-16 2004-03-09 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency
US7772371B2 (en) 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
EP1749536A1 (de) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Aktivierte Stimulatoren des Faktors X als antihämorrhagisches Mittel für die topische Anwendung
WO2016150449A1 (en) * 2015-03-23 2016-09-29 Dana Genetic A/S Recombinant soluble human tissue factor, method of its production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL64879C (de) * 1944-05-20
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin

Also Published As

Publication number Publication date
EP0266993A3 (en) 1988-07-27
EP0266993B1 (de) 1995-04-05
NZ222434A (en) 1990-06-26
ES2073391T3 (es) 1995-08-16
CA1317878C (en) 1993-05-18
DE3751218T2 (de) 1995-11-09
EP0266993A2 (de) 1988-05-11
JP2758162B2 (ja) 1998-05-28
ZA878249B (en) 1989-07-26
ATE120645T1 (de) 1995-04-15
JPS63218625A (ja) 1988-09-12

Similar Documents

Publication Publication Date Title
ATE198712T1 (de) Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE59510626D1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
DE3751218D1 (de) Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.
DE68921413D1 (de) Verbindungen und Zusammensetzungen zur Anwendung bei Methoden zur Behandlung und Prophylaxe von Pneumocystis Carinii Pneumonia und anderen Krankheiten.
DE3483330D1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
NO913129D0 (no) Nytt trombolytisk middel.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE3482889D1 (de) Verfahren zur hitzebehandlung vom blutgerinnungsfaktor viii.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE68925387D1 (de) Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.